[{"address1": "1901 West 47th Place", "city": "Kansas City", "state": "KS", "zip": "66205", "country": "United States", "phone": "913 942 2300", "website": "https://www.cingulate.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials. It also develops CTx-2103 (buspirone) that is in a formulation stage for the treatment of anxiety and mental health disorders; and plans to initiate the clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD in children, adolescents, and adults. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Mr. John A. Roberts M.B.A.", "age": 65, "title": "Executive Chairman", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 52264, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer L. Callahan CPA", "age": 53, "title": "Interim CEO, Senior VP, CFO & Secretary", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 358981, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shane J. Schaffer Pharm.D.", "age": 49, "title": "Co-Founder, CEO & Chairman of the Board (Leave of Absence)", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 570781, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raul R. Silva M.D.", "age": 66, "title": "Co-Founder, Executive VP & Chief Science Officer", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Matthew N. Brams M.D.", "age": 60, "title": "Co-Founder, Executive VP & Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 244792, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Thomas  Dalton", "title": "Vice President of Investor & Public Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nilay  Patel J.D.", "title": "Chief Legal Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.52, "open": 3.53, "dayLow": 3.46, "dayHigh": 3.635, "regularMarketPreviousClose": 3.52, "regularMarketOpen": 3.53, "regularMarketDayLow": 3.46, "regularMarketDayHigh": 3.635, "payoutRatio": 0.0, "beta": -0.77, "trailingPE": 0.026218336, "forwardPE": -0.48426813, "volume": 244006, "regularMarketVolume": 244006, "averageVolume": 137766, "averageVolume10days": 168140, "averageDailyVolume10Day": 168140, "bid": 2.55, "ask": 4.49, "bidSize": 2, "askSize": 2, "marketCap": 19845378, "fiftyTwoWeekLow": 3.02, "fiftyTwoWeekHigh": 6.01, "fiftyDayAverage": 4.3913, "twoHundredDayAverage": 4.284375, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 16841844, "profitMargins": 0.0, "floatShares": 5405000, "sharesOutstanding": 5606039, "sharesShort": 229853, "sharesShortPriorMonth": 225531, "sharesShortPreviousMonthDate": 1753920000, "dateShortInterest": 1756425600, "sharesPercentSharesOut": 0.0425, "heldPercentInsiders": 0.018129999, "heldPercentInstitutions": 0.05266, "shortRatio": 1.43, "shortPercentOfFloat": 0.0435, "impliedSharesOutstanding": 5606039, "bookValue": 1.127, "priceToBook": 3.1410825, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -17955008, "trailingEps": 135.02, "forwardEps": -7.31, "lastSplitFactor": "1:12", "lastSplitDate": 1723161600, "enterpriseToEbitda": -0.979, "52WeekChange": -0.30859375, "SandP52WeekChange": 0.1653893, "quoteType": "EQUITY", "currentPrice": 3.54, "targetHighPrice": 62.0, "targetLowPrice": 8.0, "targetMeanPrice": 27.71333, "targetMedianPrice": 20.64, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 8900183, "totalCashPerShare": 1.644, "ebitda": -17208596, "totalDebt": 6581695, "quickRatio": 1.329, "currentRatio": 1.518, "debtToEquity": 119.409, "returnOnAssets": -1.19968, "returnOnEquity": -4.1777, "grossProfits": -10680752, "freeCashflow": -9104629, "operatingCashflow": -17366526, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CING", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1758325807, "regularMarketTime": 1758312003, "exchange": "NCM", "messageBoardId": "finmb_1674914781", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.568181, "regularMarketPrice": 3.54, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1638973800000, "postMarketChangePercent": 2.8248627, "postMarketPrice": 3.64, "postMarketChange": 0.10000014, "regularMarketChange": 0.02, "regularMarketDayRange": "3.46 - 3.635", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 137766, "fiftyTwoWeekLowChange": 0.52, "fiftyTwoWeekLowChangePercent": 0.17218542, "fiftyTwoWeekRange": "3.02 - 6.01", "fiftyTwoWeekHighChange": -2.4700003, "fiftyTwoWeekHighChangePercent": -0.4109817, "fiftyTwoWeekChangePercent": -30.859375, "epsTrailingTwelveMonths": 135.02, "epsForward": -7.31, "epsCurrentYear": -3.43, "priceEpsCurrentYear": -1.0320699, "fiftyDayAverageChange": -0.85130024, "fiftyDayAverageChangePercent": -0.19386064, "twoHundredDayAverageChange": -0.7443752, "twoHundredDayAverageChangePercent": -0.17374185, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-12-08", "averageAnalystRating": "1.5 - Strong Buy", "shortName": "Cingulate Inc.", "longName": "Cingulate Inc.", "cryptoTradeable": false, "marketState": "CLOSED", "displayName": "Cingulate", "trailingPegRatio": null, "__fetch_time": "2025-09-20"}]